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Aim: To determine the outcomes of bilateral neck exploration (BNE) and uptake as well as outcomes of
minimally invasive parathyroidectomy (MIP) for primary hyperparathyroidism in a district general
hospital (DGH).
Methods: Patients who underwent ﬁrst-time parathyroidectomy for primary hyperparathyroidism
between August 1999 and December 2010 were identiﬁed from a prospectively maintained database of
a single surgeon and were analysed for outcomes of MIP and BNE. MIP was adopted in 2006 and prior to
that all patients underwent BNE. Results were analysed on an intention-to-treat basis.
Results: A total of 368 patients underwent parathyroid surgery; BNE (n ¼ 314) and MIP (n ¼ 54). Overall
cure rate was 97%. Intention-to-treat analysis, based on surgical approach, showed cure rates of 96.5%
with BNE and 96.3% with MIP (p ¼ 1.0). Of the 92 patients assessed for MIP, localisation by ultrasound
and sestamibi were noted in 60 (65%) and 65 (71%) patients respectively; however, concordance between
the scans was noted in only 54 (59%) patients. Of the 54 patients who underwent MIP, 5 (9.2%) were
converted to BNE. Intention-to-treat analysis, based on preoperative imaging, showed cure rates of 96%
with BNE and 98% with MIP (p ¼ 0.53).
Conclusions: Satisfactory cure rates for parathyroidectomy are achievable in a ‘medium-volume’ endo-
crine unit within a DGH. Preoperative localisation studies with USS and MIBI have a positive concordance
rate in only 60% of those considered for MIP, thereby limiting the use of MIP and reinforcing the role of
BNE in this era of minimally invasive surgery.
Crown Copyright  2012 Published by Elsevier Ltd on behalf of Surgical Associates Ltd. All rights
reserved.1. Background
Primary hyperparathyroidism (PHPT) is the result of excess
production of parathyroid hormone secondary to intrinsic
abnormal change in the parathyroid gland, which may be single or
multi-gland disease.1 PHPT is the third commonest endocrine
disorder and in the majority of patients is detected as an incidental
ﬁnding of high calcium.1 Treatment for PHPT is by surgical removal
of the diseased parathyroid gland(s). Traditionally, bilateral neck
exploration (BNE) was performed to identify and remove diseased
looking parathyroid glands. Over the last two decades, minimally
invasive parathyroidectomy (MIP) is being increasingly performed
and has been considered equivalent to BNE.2e5 In this approach, the
diseased parathyroid gland is localised preoperatively, predomi-
nantly (at least in the UK) by ultrasound (USS) (73%) andx: þ44 114 272 4095.
.V. Paravastu).
012 Published by Elsevier Ltd on b99TCSestamibi (MIBI) scan (82%) or less frequently by computed
tomography (CT) scan or magnetic resonance imaging (MRI)
(<5%).6 This minimally invasive approach is considered to be better
in terms of pain, smaller surgical scar and a decreased risk of nerve
injury. Further, this approach is favoured as PHPT in 85e90% of
cases is due to a single gland adenoma.1,7,8 Outcomes of BNE and
uptake and outcomes of MIP have to date been published mainly
from high volume, university hospital settings.9,10 This study
reports the outcomes of BNE and uptake as well as outcomes of MIP
in the context of district general hospital (DGH).
2. Methods
Patients who underwent ﬁrst-time parathyroidectomy for PHPT were identiﬁed
from a prospectively maintained database, which contained information on
demographics, pre, peri and postoperative calcium and parathyroid hormone levels,
the surgical approach, preoperative imaging used, postoperative complications,
conversion rate, number of abnormal glands identiﬁed, length of stay and persis-
tence and recurrence of hypercalcaemia. All those who underwent surgery between
August 1999 and December 2010 were included. MIP was initiated in March 2006
and prior to that all patients underwent BNE. A single consultant surgeon performedehalf of Surgical Associates Ltd. All rights reserved.
Fig. 1. Flow chart showing failure rates on an intention-to treat basis.
Table 2
Univariate analysis to assess factors inﬂuencing failure rate.
Variable Cured Persistent
hypercalcaemia
Failure
(%)
P value
Age (years) 64 (54e72) 59 (54e67) 0.43
Preoperative
Caþ2 (mmol/L)
2.83
(2.76e2.93)
2.81
(2.77e2.91)
0.92
Preoperative
PTH (ng/L)
102
(75e144)
110
(68e138)
0.92
Gender Male 66 3 4.34 0.72
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with a 2 cm skin incision. MIP was not routinely offered to the very young (<30
years), those with a family history of hyperparathyroidism and patients with coin-
cident goitres that were considered to hinder access. Those patients considered for
MIP underwent ultrasound scan and MIBI scans performed by experienced radiol-
ogists. MIP was offered only to those patients where there was concordance
between MIBI and USS and where imaging suggested single gland disease. All
patients had preoperative vocal cord assessment but not postoperative, unless
symptomatic. All but two patients underwent surgery under general anaesthesia.
For patients undergoing BNE, in case of four gland disease, the standard approach
was a sub-total parathyroidectomy and cervical thymectomy, leaving in-situ a small
remnant of the least diseased looking parathyroid. There was no day case service for
parathyroidectomy, both for BNE and MIP. Therefore patients stayed at least over-
night and were discharged once their calcium level was stable or normal. It was
departmental policy to check calcium levels at least on day 1 and at 6 weeks, 6 and
12 months post operation. In case of multi-gland disease calcium levels were then
checked annually. Patients were considered ‘cured’ when calcium levels remained
normal for >6 months after surgery. Persistent hypercalcaemia (or ‘failure to cure’)
was deﬁned as presence of high calcium within six months of operation.
All statistical analyses were performed using STATISTICA software package
(version 10, Bedford, UK). Continuous data are presented as median and inter-
quartile ranges (IQR), with comparison between groups performed using
ManneWhitney U-tests. Categorical variables are expressed as frequencies or
percentages, with Fisher’s exact test being used to compare outcomes between
groups.
3. Results
Between August 1999 and December 2010, 368 patients
underwent parathyroidectomy; 299 (81%) female and 69 male
(19%). 183 patients underwent surgery before (Era I) introduction of
MIP and 185 after (Era II). The median age, preoperative calcium
and parathyroid hormone levels for both eras were comparable and
presented in Table 1.
Overall cure was achieved in 355 (96.5%) patients. Persistent
hypercalcaemia was noted in 13 (3.5%) patients. Recurrence was
noted in 2 (0.5%) patients who underwent BNE, after intervals of 31
and 72 months. Temporary voice change was noted in 5 (1.3%)
patients and permanent vocal cord palsy occurred in 1 (0.2%)
patient. Of the 185 patients who underwent parathyroid surgery in
Era II, preoperative imaging with a view to MIP was performed in
92 patients. MIBI scan was performed in 91 and USS in 92 patients.
Positive ﬁnding from MIBI and USS were noted in 65 (71%) and 60
(65%) patients respectively. However, concordance between the
scans was noted in only 54 (59%) patients.
Of the 368 patients, therefore only 54 were offered MIP; the rest
underwent BNE. MIP was converted to BNE in 5 (9%) patients.
Failure was noted in 11 (3.5%) patients in BNE and 2 (3.7%) patients
in MIP group (p ¼ 1.0). Failure, by intention-to-treat basis, was
noted in 11 (4%; n¼ 272) patients in BNE and 2 (2%; n¼ 92) patients
in MIP (Fig. 1). In 5 patients who underwent BNE, abnormal para-
thyroid was not found. In 2 patients the diagnosis of a familial
hypocalciuric hypercalcaemia (FHH) was made post surgery
(despite preoperative urinary calcium excretion indices just above
the traditional cut-off between FHH and PHPT). Ectopic parathyroid
glands were noted in 3 patients. One patient each in BNE and MIP
had a missed adenoma. In a patient who underwent MIP under
local anaesthesia, adenoma was not detected and full exploration
was abandoned as patient was considered unﬁt for generalTable 1
Patient data for both Eras.
Era I (n ¼ 183) Era II (n ¼ 185)
Age (years) 64 (54e72) 63 (55e72)
Preoperative Calcium (mmol/L) 2.86 (2.77e2.97) 2.81 (2.75e2.89)
Preoperative Parathyroid
hormone levels (ng/L)
102 (70e145) 101 (78e143)
Length of stay (nights) 2 (1e2) 1 (1e1)
All data expressed as Median and Interquartile ranges (IQR).anaesthesia. Univariate analysis was performed to analyse potential
causes for failure; but there was no signiﬁcant factor identiﬁed
(Table 2).
At surgery single gland adenoma was noted in 297 (80%)
patients and multi-gland disease was noted in 58 (16%) patients. Of
the 54 patients who underwentMIP, single gland diseasewas noted
in 52 patients and in two patients there was multi-gland disease,
discovered at surgery by visualisation of a second abnormal glandFemale 289 10 3.34
Imaging performed Y 90 2 2.08 0.53
N 265 11 4.04
MIBI þve 63 2 3.08 1.0
ve 26 0 0.00
USS þve 58 2 3.33 0.54
ve 32 0 0.00
Era I 173 10 5.46 0.052
II 182 3 1.62
Total number of patient (n) ¼ 368.
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to BNE. Parathyroid gland weight tended to be lower in patients
undergoing BNE compared to MIP; Median (IQR) ¼ BNE: 0.55
(0.28e1.16) g; Unilateral: 0.63 (0.36e0.78) g; Focussed: 0.68
(0.4e1.09) g; Focussed converted: 1.40 (0.75e1.84) g
(KruskaleWallis ANOVA; H ¼ 7.006, 3df, p ¼ 0.072). Likewise, the
sensitivity of MIBI and USS was closely correlated with parathyroid
gland weight (Table 3).
4. Discussion
This is the ﬁrst comprehensive report of outcomes of BNE and
uptake of MIP in a DGH in the UK, in the era of minimally invasive
surgery. Most previous studies from the UK were from high volume
or university hospitals.11e13 One recent report from a district
general hospital only presented results of minimally invasive
parathyroidectomy.14 The results of this prospective study show the
feasibility of obtaining satisfactory cure rates for parathyroid
surgery in a ‘medium-volume’ DGH endocrine unit, which compare
favourably to those reported elsewhere.6 Single gland disease in
our populationwas found in only 80%, whereasmulti-gland disease
was noted in 16%. This is slightly higher than that quoted tradi-
tionally (85%e90%)1,7 but consistent with the data from BAETS
national audit,6 which reported the incidence of multi-gland
disease as 18.6%. Overall, success rate of 96.5% was similar to that
noted in larger centres9,11 and consistent with the data from BAETS
national audit which reported 95.6% overall success rate.6
Published literature from pioneering centres show that MIP is
being offered as the ﬁrst line approach.9,10,15,16 However, in the UK,
there is no national guideline on the surgical approach for para-
thyroidectomy and The British Association of Endocrine and
Thyroid Surgeons (BAETS) only recommend a target cure rate of
95% without any emphasis on the surgical approach. In this series
MIP was undertaken in the minority of cases as the technique was
only introduced locally in 2006; uptake of MIP was initially
cautious, due to the need to establish local radiological expertise in
performing accurate localisation studies, plus a degree of surgical
conservatism; and localisation studies proved concordant in only
around 60% of cases. Many published series of MIP report only
those cases initially undergoing focussed surgery14,17,18 and have
a limitation in that the outcomes for the whole group of PHPT
patients are not stated. It is possible that patients undergoing
focussed surgery are a select groupwith ‘easier to cure’ disease,19 so
it remains important to report outcome for all operated cases, as
detailed here. This study, however, did not demonstrate any decline
in success rate of BNE after introduction of MIP, and, in line with
other centres, MIP is currently offered routinely, in the absence of
the contra-indications mentioned above.
The results of our study also conﬁrmed that sensitivity of MIBI is
dependent on the weight of parathyroid adenoma and therefore,
patients undergoing BNE had smaller adenomas compared to those
undergoing MIP. These results are similar that of Golstein et al.20
and a recent study, where the authors demonstrated that patients
with multi-gland disease have signiﬁcantly smaller parathyroid
glands compared to thosewith single gland disease and that MIBI is
less sensitive in detecting multi-gland disease.21 Because MIBITable 3
Sensitivity of MIBI and USS by parathyroid gland weight.
Imaging Weight [Median (IQR)] grams P value
MIBI ve 0.34 (0.19e0.82) 0.01
MIBI þve 0.68 (0.36e1.17)
USS ve 0.3 (0.19e0.82) 0.002
USS þve 0.70 (0.38e1.17)works by accumulating in the mitochondria-rich oxyphil cells of
the parathyroid gland, uptake is dependent on the size and cellular
function of the gland.22 This explains the low sensitivity of MIBI in
detecting hyperplastic glands (which are usually smaller, or where
variability in cellular activity is likely to exist between different
glands in the same patient) compared to adenomas.22 The sensi-
tivity of USS in our study, similar toMIBI, is limited by the size of the
adenoma. USS can detect adenomas of 100 mg, however, higher
rates of diagnosis have been reported with adenomas of
>500 mg.23
Our study highlights that preoperative MIBI and USS were
concordant in only up to 60%. These results are similar to that
reported by Mihai et al. (57%)11 and slightly higher than that
reported by McVeigh et al. (52%).12 5 patients were converted to
BNE. This was slightly higher than the 2% reported by the Mayo
clinic group,9 but comparable to that reported in a large Australian
series (7.4%)24 and similar to that reported by BAETS (8.6%).6
Conversion to BNE or unilateral exploration was considered in
our series, when there was non-concordance between the surgical
ﬁndings and that of preoperative imaging, when a second abnormal
gland was seen, and when the adenoma was too large to be
retrieved safely from a small incision. This was reﬂected by the
ﬁnding of higher total parathyroid gland weight in the converted
group compared to the focussed or the BNE groups.
The failure rates from BNE and MIP were similar, at 3.5% and
3.7% respectively (p ¼ 1.0), consistent with most published studies
which have compared both approaches.9,11 We did not identify any
factors predictive of failure to cure, although there was a trend to
higher cure rate in era 2 compared to era 1. This might be explained
by chance alone (p¼ 0.052, but with a small number of events there
was a moderate probability of a Type II error) or a genuine reduc-
tion in failure rate over time. Success rates did not differ between
cases undergoing imaging and those proceeding straight to BNE,
whilst only one of the three failures in Era II was from BNE
(n ¼ 131); the rest in MIP (n ¼ 54). Therefore, any difference in
results between era 1 and era 2 did not result from the performance
of imaging per se. The improvement in cure rate noted in Era II
could, however represent progress in operative success rate with
enhanced experience. The CUSUM curve shown in Fig. 2, might be
interpreted as showing evidence of such a post-graduate learning
curve, with a ﬂattening out in event rate starting at about cases
150e180. If so, and assuming this is not unique to this centre, this
might have implications for training and/or mentoring of future
endocrine surgeons, particularly as the senior author’s training hadFig. 2. CUSUM curve of failure rate with operative experience.
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formed with/without assistance and 22 assisting) prior to 1999,
which is much higher than the currently recommended BAETS
guidelines requiring a trainee to have performed 10 and assisted 20
parathyroidectomies prior to completion of training.25
There is now compelling evidence to show that outcomes
improve with volume of workload in specialties like vascular
surgery.26 Only a handful of studies have attempted to look at such
a relation in endocrine surgery. A survey by Sosa et al. showed that
surgeons performing >50 cases per annum had a signiﬁcantly
lower complication, re-operation and mortality rates.27 Mitchell
et al.28 showed a signiﬁcantly higher number of re-operations in
centres performing <20 parathyroidectomies compared to those
performing >20 per year. Chen et al.29 also demonstrated that
centres performing >50 cases per year have a lower complication
rate compared to those performing less than 50 per year. Stavrakis
et al.30 also showed similar results. It is interesting to note from
their study that only 7% of the 2215 surgeons involved performed
more than 20 cases per year. All these studies show that the
outcomes are better with experience. Our centre, based on the
above, would classify as a medium volume centre, performing >30
cases per year, and the results suggest that this volume of cases is
adequate tomaintain and demonstrate good outcomes, comparable
to those of higher volume centres.
Intra-operative PTH assay was used in the early part of our
experience with MIP, but abandoned due to the delay in obtaining
results and lack of a dedicated analyser based in theatre. The
difﬁculty in obtaining IOPTH measurement may not be limited to
our centre as the BAETS audit reports that only a third of its
registered members use IOPTH.6 Our cure rate of 96.5%, largely
without IOPTH, however, compares favourably with most previous
published studies.10,11,24
The cost-effectiveness of MIP was not directly examined in this
study. The costs incurred with MIP are operating theatre costs
similar to BNE, along with costs of preoperative localisation studies
and in some centres, intraoperative monitoring adjuncts. It is
perceived that additional costs of imaging are nulliﬁed by improved
operative success and decreased hospital stay, however, most pub-
lished studies, including this study, reported comparable outcomes
between both surgical approaches. One study fromOxford, reported
higher costs for MIP compared to BNE, evenwhen hospital stay and
operative timeswere taken in to consideration alongwith operative
success rate.31 In our study, the median length of stay in Era I was 2
days compared to that in Era II, which reﬂects the current trends in
minimising hospital stay for surgery and a similar trend was
reported by BAETS (2009). Nationally, most BNE are nowperformed
as 24-h stay cases, while currently only 10% of targeted procedures
are being performed as true day cases (BAETS 2009), which may be
underestimating the potential cost-beneﬁt of MIP.
Due to the study design, our resultsmay have some confounding
factors. Firstly, it is possible that the observed recurrence rate is an
under-estimate of the true rate. Patients with single gland adenoma
did not have any routine hospital follow up after one year. Only
patients with multi-gland disease had routine annual calcium
checked. However, being a district hospital setting, with a single
surgeon practice, it is likely that the authors would have been
notiﬁed or referred back any symptomatic recurrence. Further-
more, the Trust’s electronic biochemistry database was interro-
gated prior to analysis of this series, in order to identify recent
calcium estimates for each case. The two patients with recurrence
in this study may therefore be a realistic reﬂection of at least
symptomatic recurrence. Similarly, vocal cord palsy might have
been under-estimated, as laryngoscopy was not performed
routinely post-operatively, but rather selectively if symptoms of
voice change existed.32These limitations aside, however, it is obvious that for the
primary outcome measure of biochemical cure of PHPT, satisfac-
tory results for parathyroidectomy could be achieved outside
a large tertiary referral centre. Though the uptake of MIP was slow,
most patients are now being considered for this approach.
Preoperative localisation studies with USS and MIBI have a positive
concordance rate in only 60% of those considered for MIP, thereby
limiting the use of MIP and reinforcing the role of BNE in this era of
minimally invasive surgery. Cure rates with MIP, without the use of
IOPTH, are comparable to BNE. Parathyroid surgery in the UK is
predominantly consultant led and up to 78% of all ﬁrst time and
95% of recurrent procedures are being performed by consultants.6
From a training point of view, it is therefore vital that all surgeons
performing parathyroidectomy should have the expertise in per-
forming BNE as well as MIP. Emphasis should be given regarding
both techniques, in training all future endocrine surgeons.
Although BAETS (2003)25 curriculum requires a trainee to perform
10 or assist 20 parathyroidectomies, it is possible that an indi-
vidual surgeons’ total experience in parathyroidectomy is relevant,
beyond Specialist Registrar training, and this may ultimately be
more relevant than the differences between DGH and Teaching
Hospital settings.
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